?????? ?? ???????????? ?????????? ???? ?????????????????? ?????? ???????? ????????????? In our latest Q&A, Sara Contu and Bethany Knorr Chung, PhD, RAC discuss the power of the PRISMA chart in literature reviews. ?? ?????? ????????????: ?? Visual Clarity: A PRISMA chart offers a clear visual representation of your decision-making process. ?? Transparency: It shows inclusion/exclusion criteria across screening levels, ensuring transparency and systematic review. ?? Regulatory Compliance: This clarity helps meet regulatory standards and avoids protocol non-conformity issues. Ready to enhance your literature reviews? Let’s connect! Comment below or leave us a message! #MedTech #MedTechInnovation #RegulatoryCompliance #SmartAuthoring #Fern #AI #Confidence ?#Clarity #Compliance #EUMDR #EUIVDR #FDA #HealthCanada #UKCA #NMPA #Regulations #DigitalSolution #SmartAuthoring #SmartKeys #LiteratureReview
Fern.ai的动态
最相关的动态
-
Let’s meet at DIA's 2025 Regulatory Submissions, Information, and Document Management Forum, February 3-5, Bethesda, MD. https://lnkd.in/eQETrRuy Meet Court Square Group and talk about the latest trends, innovations, and best practices in regulatory submissions, information, and document management (RSIDM)! #clinicaltrials?#clinicaldata #ai #Quality #Validation #compliance #21cfrpart11
要查看或添加评论,请登录
-
-
Take a look at what's changed with the modernized HIMSS AMAM Maturity Model! Is your healthcare organization ready to assess?
Take your data to the next level with HIMSS. ? Uncovering knowledge and insights that drive better outcomes just got easier with our digital health solutions, now laser-focused on evidence-based outcomes, ethics, and scalable strategies for your entire team.?Lock into competencies that address the impact of analytics, the adoption of AI in health, and its role in digital maturity. Come take a look at what's changed: https://bit.ly/3LCwQEN
要查看或添加评论,请登录
-
Revolutionizing Healthcare AI: The Power of Precision Claude Shannon and Max Planck's groundbreaking work in communication and physics now enhances healthcare AI. Shannon pioneered information theory in 1948, enabling efficient data transmission. Planck founded quantum theory in the early 1900s, explaining energy's behavior. Their innovations now improve healthcare AI accuracy. Key Benefits of Precision AI in Healthcare ?- Improved diagnosis accuracy - Personalized treatment plans - Enhanced patient safety - Predictive analytics - Optimized resource allocation - Data-driven decision-making - Customized disease management Let's harness the power of data science for better healthcare outcomes! Learn how precision AI transforms healthcare outcomes here. (https://shorturl.at/7UTuu) #HealthcareAI #PrecisionMedicine #DataScience ***************** Follow for cool, exciting and latest innovation updates along with thoughtful articles in the field of AI, Health and Design. Learn more about my work at helloDeepakSingh.com
要查看或添加评论,请登录
-
Take your data to the next level with HIMSS. ? Uncovering knowledge and insights that drive better outcomes just got easier with our digital health solutions, now laser-focused on evidence-based outcomes, ethics, and scalable strategies for your entire team.?Lock into competencies that address the impact of analytics, the adoption of AI in health, and its role in digital maturity. Come take a look at what's changed: https://bit.ly/3LCwQEN
要查看或添加评论,请登录
-
As differences between states' compliance frameworks grow, Bloomberg Law is here to help. Join our webinar – State Law Power: What the Maps Portend in 2025 – to explore requirements across jurisdictions and prepare for the year ahead. In a panel moderated by Robert Combs, BLaw analysts will break down post-Chevron regulatory power, drug pricing, deepfake AI, and more: https://lnkd.in/exNNf8u4
要查看或添加评论,请登录
-
-
Exaggeration of Reality? During the COVID period, many US-focused sponsors realized for the first time the limitations of remote monitoring in the EU—no remote access to patient data allowed, no SDV. This caused significant distress and meltdowns. Now, in the post-COVID era, sponsors are more aware of the strict data protection laws in the EU. In bid defenses, US-based sponsors often ask CROs how they manage this aspect, in case on-site visits become limited again. My advice: be prepared and review your SOPs. If your company doesn’t have a guideline for this scenario, suggest developing one! How do you answer this question? Share it in the comments. _____________________________________________ To stay up-to-date with our industry follow me on LinkedIn and subscribe to my newsletter on misterclinical.com I write about Trends, News, Career, Leadership, AI in Clinical Research. Cheers! Vitali
要查看或添加评论,请登录
-
-
As differences between states' compliance frameworks grow, Bloomberg Law is here to help. Join our webinar – State Law Power: What the Maps Portend in 2025 – to explore requirements across jurisdictions and prepare for the year ahead. In a panel moderated by Robert Combs, BLaw analysts will break down post-Chevron regulatory power, drug pricing, deepfake AI, and more: https://lnkd.in/eFFWjsx5
要查看或添加评论,请登录
-
-
?????? ???? ?????? ??????????????????: ?????? ?????? ?? ???????????????? ?????????????? ?????? ????????'?? ?????? ???????????? The EU AI Act has already drawn significant criticism for its far-reaching impact on businesses across various sectors. Join us for this important event, where I will jointly with Martina Gavalec and Sa?a Sodja uncover the most pressing challenges posed by the AI Act. We’ll highlight the top critical business impacts companies must be prepared for. We are also excited to welcome Leif-Nissen Lundb?k, PhD, CEO and Founder of Xayn AG, who will share his first-hand experience of implementing the AI Act. ?? Date: 5 November 2024 ?? Time: 5.30 – 8.00 CET ?? Where: Join us live at CMS RRH in Vienna or online via CMS Webinar Whether you prefer to attend in person or virtually, this session is a must for business leaders, in house lawyers and compliance professionals looking to stay ahead of regulatory demands. Register now via the link in the comments?below! #EUAIAct #ArtificialIntelligence #CMSLaw
要查看或添加评论,请登录
-
For those that believe there is some validity in #ai certification, but don’t believe in central control or “assurance labs”, there is an emerging set of voices advocating for a “federated” register populated using local control, similar to the “clinical trials” model. It would set federal guidelines, but leverage local experts to “vet” and maintain the models, giving more visibility and more autonomy. https://lnkd.in/e6JfNnyp https://lnkd.in/eXDiy6-Z
要查看或添加评论,请登录
-
As differences between states' compliance frameworks grow, Bloomberg Law is here to help. Join our webinar – State Law Power: What the Maps Portend in 2025 – to explore requirements across jurisdictions and prepare for the year ahead. In a panel moderated by Robert Combs, BLaw analysts will break down post-Chevron regulatory power, drug pricing, deepfake AI, and more: https://lnkd.in/ehsaUciP
要查看或添加评论,请登录
-